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Abstract
This study examines the influence of a successful PCI upon preoperative patient profile, peroperative management and postoperative,
including one-year follow-up, results. From January 1999 through December 2001, 1141 patients (91%) underwent coronary artery bypass
grafting (CABG) as the primary intervention for myocardial revascularization (group A) and 113 patients (9%) underwent primary CABG
after an initially successful PCI (group B). Patients undergoing CABG after a failed PCI were not included. Patients in group B were
statistically significant younger (Ps0.010), with more peripheral arterial vascular (Ps0.015) and renal disease (Ps0.036). Left main
coronary artery stenosis was significantly lower in group B (Ps0.004). The number of diseased vessels did not differ between the two
groups. However, less distal anastomoses were performed in group B (Ps0.001). Postoperatively there was no statistically significant
differences, in the percentages of myocardial infarction, arrhythmias, reinterventions, neurological, renal and pulmonary complications,
and hospital mortality. One-year follow-up did not show any statistically significant differences in cardiac related mortality (Ps0.25) or
recurrent ischemic events (Ps0.27). Multivariate analysis did not identify a successful PCI as a risk factor for early and late adverse
outcomes. Previous PCI does not seem to result in a higher postoperative mortality or morbidity after CABG.
 2005 Published by European Association for Cardio-Thoracic Surgery. All rights reserved.
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1. Introduction
Since the introduction of percutaneous coronary interven-
tion (PCI) as an alternative myocardial revascularization
procedure to coronary artery bypass grafting (CABG) several
studies have been published comparing the outcomes of
CABG and PCI as the primary treatment for coronary artery
disease w1–3x. At the same time reports have been pub-
lished about the changing population being offered primary
CABG w4–6x. Beside the increase of age and co-morbidity,
there are an increasing number of patients with a previous
successful PCI in the present population of patients under-
going CABG w5x.
It is supposed that this cohort of patients with a previous
PCI is at higher risk for CABG. However, only a few studies
are available and contradictory: some authors suggest that
initial PCI may complicate the operation and may increase
postoperative morbidity and mortality w7x. Others describe
no difference in postoperative morbidity and mortality w8x.
The aim of our study was to examine if patients who had
undergone previously successful PCI and required subse-
quent CABG do have a higher operative risk compared to
patients treated by CABG as the primary intervention. Not
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only hospital mortality and morbidity were analyzed, but
also the results at one year postoperative.
2. Patients and methods
2.1. Patients
The Coronary Surgery Database at Radboud Hospital (COR-
RAD), a registry that stores pre-, peri-, postoperative, and
follow-up data of all patients undergoing cardiac surgery
at the University Medical Centre St. Radboud, Nijmegen,
The Netherlands, was used to identify patients who had
undergone primary isolated CABG from January 1999
through December 2001. 1141 Patients (91%) underwent
CABG as the primary intervention (group A) for a myocardial
revascularization and 113 patients (9%) who previously had
undergone successful PCI required subsequent CABG (group
B). A successful PCI was defined as dilation of an coronary
stenosis (or stenoses) such that the residual luminal nar-
rowing was less than 10% and unassociated with a flow-
limiting dissection or the need for immediate CABG.
Patients undergoing an emergency-CABG after a failed PCI
and patients who had unsuccessful PCI were not included
in group B.
Patient baseline characteristics analysed included patient
gender, age and diabetes mellitus, hypertension, hyperli-
pidemia, smoking history and family history of coronary
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Table 1
Definitions of patient characteristics and events
Age Years
Gender Male, female
Diabetes mellitus Diet-controlled, oral therapy or insulin dependent diabetes
Hypertension Systolic blood pressure )160 mmHg, or diastolic pressure
)100 mmHg, or antihypertensive medication
Hyperlipidemia Total cholesterol )250 mgydl or triglyceride level )200
mgydl
Smoking Current smoking (including patients stopped less than one
year before CABG)
Family history Family history of coronary, cerebrovascular or vascular
disease
Peripheral vascular disease Peripheral vascular pathology or operation
Neurological disease Stroke andyor transient ischemic attack
Renal disease Renal failure (creatinine G150 mmolyl – mgydl),
preoperative dialysis, renal transplantation
Pulmonary disease Chronic obstructive pulmonary disease andyor history of
previous lung disease
Preoperative M.I. History of myocardial infarction before the operation
Arrhythmia Absence of sinus rhythm
Left main Left main coronary artery stenosis )50%
Left ventricular function Ejection fraction: Good )50%; Moderate )30%, -50%;
Poor -30%
NYHA New York Heart Association classification
ECC Extracorporal circulation, duration in minutes
AoX Aortic cross-clamp time, duration in minutes
Endarterectomy Endarterectomy of at least one major coronary artery.
Perioperative M.I. A new Q wave and a CK-MB G10% of total CK
Reintervention Reoperation for bleeding or tamponade
Stroke Postoperative cerebrovascular accidents andyor transient
ischemic attack
Renal complications Postoperative renal failure (creatinine G150 mmol yl –
mgydl) or dialysis
Pulmonary complications Postoperative pulmonary infection
Hospital stay Postoperative days at the cardiac surgery center UMCN-st
Radboud, Nijmegen
Hospital mortality All cause of mortality during postoperative hospital stay
at the cardiac surgery centre
artery disease as risk factors for ischemic heart disease.
Preoperative co-morbidity included peripheral ischemic
vascular, neurological, renal and pulmonary disease. Pre-
operative cardiac status included myocardial infarction,
arrhythmia, left main coronary artery stenosis and the
degree of coronary vessel disease (1-, 2- or 3-vessel disease
a the time of indication for CABG) and decreased left
ventricular function.
In both groups the duration of extracorporeal circulation
(ECC) and aortic cross-clamp time (AoX), the number of
grafts and distal anastomoses and the number of endarte-
rectomies were compared.
Postoperative complications assessed included arrhyth-
mia, perioperative myocardial infarction, reintervention
and neurological, renal and pulmonary complications, and
also hospital mortality. The definitions of these patient
characteristics are described in Table 1.
2.2. Follow up
Our follow-up concerned the first postoperative year and
was complete except for 1 patient of group A (0.09%).
These data are the results of our yearly-organized follow-
up. This follow-up consists of a written survey directed to
all patients. In this survey mortality, and non-fatal cardiac
events are registered. Mortality was divided in cardiovas-
cular related and non-cardio-vascular related mortality. A
new non-fatal event was registered as a new myocardial
infarction, the return of angina pectoris, a positive tread-
mill test after a negative one, coronary angioplasty, rein-
tervention, congestive heart failure, arrhythmia or stroke.
2.3. Statistic analysis
Characteristics of patients are presented as percentages
for dichotome variables, and as mean " standard devia-
tion, and range for numerical variables. Differences in
percentages were tested with the chi-square test, and
numerical variables were tested with the t-test. To identify
if a PCI is an independent significant risk factor for negative
outcome, multivariate logistic regression analysis was used
to identify pre-and postoperative risk factors that indepen-
dently contributed to hospital mortality, cardiac related
mortality and non-fatal cardiac events at one year postop-
erative. Statistical significance was assumed at PF0.05.
3. Results
3.1. Patient characteristics at baseline
Patient characteristics before CABG are outlined in Table
2. There were no significant differences between group A
and B for gender and for the incidence of diabetes mellitus,
hypertension, hyperlipidemia, smoking history and family
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Table 3
Operative characteristics
Group A Group B P-value
Ns 1141 (%) Ns113 (%)
ECC (minutes) 79.9"38.7 72.0"39.3 0.039
AoX (minutes) 43.0"25.8 38.3"25.4 0.063
Number of grafts 2.0"0.9 1.9"0.2 0.150
(1–3) (1–3)
Number of distal anastomoses 3.2"1.3 2.2"0.9 0.001
(1–5) (1–6)
Endarterectomy 35 (3.1) 1 (0.9) 0.180
Table 2
Patient characteristics at baseline (before CABG)
Group A Group B P-value
Ns1141 (%) Ns113 (%)
Gender 0.200
Men 836 (73.3) 89 (78.8)
Women 305 (26.7) 24 (21.2)
Age (yrs) 64.2"10.6 61.5"10.9 0.010
Diabetes mellitus 69 (6.1) 10 (8.8) 0.240
Hypertension 612 (53.6) 71 (62.8) 0.610
Hyperlipidemia 636 (55.7) 71 (62.8) 0.140
Smoking history 637 (55.8) 62 (54.0) 0.860
Family history of coronary disease 604 (52.9) 64 (56.6) 0.720
Peripheral vascular disease 132 (11.6) 22 (19.5) 0.015
Neurological disease 97 (8.5) 11 (9.7) 0.650
Renal disease 37 (3.2) 8 (7.1) 0.036
Pulmonary disease 92 (8.1) 11 (9.7) 0.530
Myocardial infarction 506 (44.3) 53 (46.9) 0.600
Arrhythmia 48 (4.2) 5 (4.4) 0.910
Left main coronary artery stenosis 200 (17.5) 8 (7.1) 0.004
Mean number of diseased vessels 2.5"0.7 2.4"0.4 0.080
range 1–3 1–3
NYHA 0.24
Class I 23(2)
Class II 108 (9) 12 (10)
Class III 799 (70.0) 77 (70)
Class IV 221 (19) 24 (20)
Left ventricular function 0.890
Good 1090 (95.5) 107 (94.7)
Moderate 36 (3.2) 4 (3.5)
Poor 15 (1.3) 2 (1.8)
history of coronary disease. The presence of neurological
and pulmonary disease was not significantly different
between group A and B.
Patients in group B were statistically significant younger
than patients in group A and patients in group B had more
peripheral ischemic arterial vascular disease and renal
disease. The percentage of patients with a left main
coronary artery stenosis was significantly lower in group B.
The incidence of preoperative acute myocardial infarction,
arrhythmia, left ventricular dysfunction, number of dis-
eased vessels, and NYHA class did not differ significantly
between group A and B.
3.2. Operative characteristics
The duration of extracorporeal circulation was obviously
shorter in group B than in group A, and patients in group B
had less distal anastomoses than patients in group A. The
aortic cross-clamp time, the number of grafts and the
incidence of endarterectomy were not significantly differ-
ent between the two groups.
These operative data are outlined in Table 3.
3.3. Postoperative outcome and first year of follow-up
Postoperatively there was no significant difference, nei-
ther in percentages of arrhythmia, myocardial infarction,
reintervention and neurological, renal and pulmonary com-
plications, nor in hospital mortality and hospital stay.
Follow-up results showed no significant differences in car-
diac related mortality and recurrent non-fatal ischemic
events.
These data are shown in Table 4.
3.4. Multivariate logistic regression analysis
The results of multivariate logistic regression analysis
were presented in Table 5. Important is that PCI is not
identified as independent variable for hospital-, cardiac
related mortality, and recurrent non-fatal ischemic events
at one year postoperative.
For hospital mortality, age, pulmonary disease, left main,
NYHA, left ventricular function, perioperative myocardial
infarction, reintervention, renal complications and stroke
were identified as independent variables as expected. For
one-year cardiac related mortality only the number of
diseased vessels disease were identified. For non-fatal
ischemic events during the first postoperative year, pul-
monary disease, preoperative myocardial infarction and
postoperative arrthythmia were identified.
4. Discussion
Since the introduction of percutaneous coronary interven-
tion an increasing number of patients undergoing isolated
coronary artery bypass surgery have had previously suc-
cessful PCI. The differences between this patient-popula-
tion and patients treated primary by CABG as the therapy
for coronary artery disease have hardly been studied w7,8x,
while many reports have been published about the com-
parison of outcomes of primary CABG and primary PCI w1–
3x and about the differences between patients treated by
PCI and patients initially treated by PCI later requiring
CABG w9,10x. Other reports described the changing popu-
lation being offered primary CABG w4–6x.
Here, we present a large study on the preoperative,
peroperative and postoperative differences between
patients treated primary by CABG and patients initially
treated by PCI and later required CABG. We used these
data from our database (CORRAD) to assess the difference
in operative risk between both groups. Patients undergoing
an emergency-CABG with or without a failed PCI and
patients who had undergone PCI unsuccessfully were not
included. This was appropriate because patients undergoing
emergency-CABG are in any case at higher risk because of
their myocardial ischemia, and patients who had undergone
unsuccessful PCI do not belong to our target group.
Patients with previous PCI were three years younger and
had more peripheral arterial and renal disease. This may
point to a more aggressive form of atherosclerosis. In both
groups the percentages of diabetes mellitus, hypertension,
hyperlipidemia, smoking history and family history of cor-
onary disease as risk factors for ischemic heart disease
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Table 4
Postoperative outcome and first year of follow-up
Group A Group B P-value
Ns1141 (%) Ns113 (%)
Arrhythmias 78 (6.8) 6 (5.3) 0.53
Myocardial infarction 68 (6.0) 10 (8.8) 0.22
Reintervention 14 (1.2) 2 (1.8) 0.81
Stroke 20 (1.8) 3 (2.7) 0.49
Renal complications 66 (5.8) 10 (8.8) 0.19
Pulmonary complications 89 (7.8) 12 (10.6) 0.29
Hospital mortality 24 (2.1) 4 (3.5) 0.32
Hospital stay (days) 0.41
Mean"SD 8.3"9.4 8.2"9.0
Median 6 6
Range 0–123 0–94
Follow-up Ns1117 (%) Ns109 (%)
Recurrent non-fatal event 55 (4.9) 8 (7.3) 0.27
Cardiac related mortality 13 (1.2) 0 0.25
Lost to follow-up 1 0
Table 5
Multiple logistic regression analysis for adverse outcomes
Variable Hospital One-year Non-fatal
mortality cardiac
related
mortality
recurrent
events
P-value Odds P-value Odds P-value Odds
PCI 0.41 1.02 0.31 1.03 0.34 1.03
Gender 0.37 1.02 0.46 1.02 0.10 1.04
Age 0.00 1.07 0.92 1.00 0.11 1.05
Diabetes 0.71 1.04 0.96 1.00 0.62 1.01
Hipertension
´
0.73 1.00 0.25 1.03 0.67 1.01
Hyperlipidemia 0.96 1.00 0.06 1.05 0.07 1.06
Peripheral vascular disease 0.06 1.04 0.41 1.02 0.85 1.00
Neurological disease 0.69 1.01 0.20 1.04 0.92 1.00
Renal disease 0.18 1.03 0.81 1.00 0.68 1.01
Pulmonary disease 0.03 1.05 0.31 1.03 0.02 1.07
Preoperative M.I. 0.91 1.00 0.15 1.04 0.00 1.14
Arrhythmia 0.84 1.00 0.37 1.03 0.63 1.01
Diseased vessels 0.71 1.00 0.04 1.05 0.37 1.02
Left main 0.006 1.07 0.27 1.03 0.41 1.02
NYHA 0.04 1.05 0.98 1.01 0.66 1.01
Left ventricular function 0.00 1.11 0.68 1.12 0.08 1.05
Postoperative arrhythmia 0.48 1.02 0.60 1.01 0.01 1.08
Perioperative M.I. 0.00 1.12 0.82 1.00 0.37 1.02
Reintervention 0.00 1.09 0.80 1.00 0.96 1.00
Renal complications 0.00 1.11 0.39 1.03 0.68 1.01
Stroke 0.00 1.34 0.53 1.02 0.13 1.04
Pulmonary complications 0.34 1.02 0.53 1.02 0.40 1.02
Ps0.00 means PF0.001
were similar. So, patients who had undergone previously
successful PCI and needed CABG were smoking as much as
patients who needed to be treated by primary CABG. This
underlines again the difficulty for patients to quit smoking,
even if they have a motive in the past w11x.
The percentage of patients with a left main coronary
artery stenosis was significantly lower in patients with a
previous PCI, which was expected because patients with a
left main coronary artery stenosis have the preference in
our centre to be treated by CABG rather than PCI. The
number of diseased vessels was not significantly different
between both groups, but we have no clear explanation
why the duration of extracorporeal circulation was obvi-
ously shorter in patients with previous PCI. Although there
was a lower number of distal anastomoses, but this was
not reflected in a shorter aortic cross clamp time. The
number of grafts was not different, so that performing
more proximal anastomoses, during reperfusion, is not the
argument for a longer perfusion time. Although the degree
of vessel disease was not different in both groups, the
significantly higher number of distal anastomoses and the
higher percentage of endartertomies in patients without
previous PCI suggests a more extended form of atheroscle-
rosis in this group, probably a reason for a longer reperfu-
sion time after cross-clamp removal. The lower number of
distal anastomoses suggests also a good result of the
previous PCI.
Postoperatively, there was no difference in complications
and the follow-up results did not show differences in
cardiac related mortality and recurrent non-fatal ischemic
events.
Multivariate stepwise regression analysis confirmed that a
previous PCI did not predispose to mortality and recurrent
non-fatal ischemic events after CABG. So, there is no
indication that a previous successful PTCA results in a higher
postoperative mortality or morbidity or poorer results after
primary CABG. Interesting in our multivariate analysis is
the identification of age, pulmonary disease, preoperative
myocardial infarction, diseased vessels, left main, NYHA,
left ventricular function, reintervention, postoperative
arrhythmia, perioperative myocardial infarction, renal com-
plications and stroke as independent risk factors for an
impaired outcome. Most of these variables were also iden-
tified in other risk-analysis for mortality and return of
ischemic events after CABG w12x.
There are several limitations in our study. The most
important is the absence of cardiac data, as vessel disease,
ejection fraction, NYHA-class, event-free period,of group B
at the moment of the PCI. As already mentioned in this
discussion, we can suggest a more extended form of ath-
erosclerosis in group A and we suggest a good result of the
previous PCI. It would be nice if we could retrieve all pre-
PCI cardiac data. However, several of these patients had
their PCI at another cardiac center, and several of them in
an acute situation, so that only a few of the representative
data were available. Another weakness may be that most
of the studied patients were operated on between 1999
and 2001, and were not stented during their PTCA before
the operation. However, this still reflects current practice
in 2004.
In conclusion, our study suggests, in contrast with other
studies w9,10x, that there is no indication that a previously
successful PTCA result in a higher postoperative mortality
or morbidity or poorer results after CABG. Therefore,
patients with previous successful PCI, who have recurrent
angina, may be good candidates for primary CABG.
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